Is sentinel lymph node mapping relevant for colon cancer? A feasibility study;Intérêt de l'analyse du ganglion sentinelle pour les cancers coliques: Étude de faisabilité

Annales de Chirurgie

Volumn 128, Issue 7, 2003, Pages 433-437

  Lasser, P ^a   Cote J F ^a   Sabourin, J C ^a   Boige, V ^a   Elias, D ^a   Duvillard, P ^a   Pocard, M ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Colon cancer; Sentinel lymph node; Surgery

Indexed keywords

CYTOKERATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL ARTICLE; COLON CANCER; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; SENTINEL LYMPH NODE; TECHNIQUE;

EID: 10744220286     PISSN: 00033944     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-3944(03)00178-0     Document Type: Article

References (22)

1. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
2. Morton DL, Wen DR, Wong JH, Economous JS, Cagle LA, Storm FK, et al. Technical details of intra-operative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
3. Bellocq JP. Le ganglion sentinelle dans le cancer du sein. Ann Pathol 2000;20:S119-25.
4. Nieweg OE, Rutgers EJT, Jansen L, Valdès Olmos RA, Peterse JL, Hoefnagel KA, et al. Is lymphatic mapping in breast cancer adequate and safe? World J Surg 2001;25:780-8.
5. Pocard M, Elias D. Techniques et méthodes nouvelles en chirurgie des cancers digestifs. Bull Cancer 2001;88:55-8.
6. Joosten JJA, Strobbe LJA, Wauters CAP, Pruszczynski M, Wobbes Th, Ruers TJM. Intra-operative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999;86:482-6.
7. Saha S, Wiese D, Badin J, Beutler T, Nora D, Ganatra BK, et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 2000;7:120-4.
8. Merrie A EH, van Rij AM, Philips LV, Rossaak JI, Yun K, McCall JL. Diagnostic use of sentinel node in colon cancer. Dis Colon Rectum 2001;44:410-7.
9. Esser S, Reilly WT, Riley LB, Eyvazzadeh C, Arcona S. The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum 2001;44:850-6.
10. Feig BW, Curley S, Lucci A, Hunt KK, Vauthey JN, Mansfield PF, et al. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg 2001;182:707-12.
11. Waters GS, Geisinger KR, Garske DD, Loggie BW, Levine EA. Sentinel lymph node mapping for carcinoma of the colon: a pilot study. Am Surg 2000;66:943-5.
12. Bilchik AJ, Nora D, Tollenaar RA, van de Velde CJ, Wood T, Turne R, et al. Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer 2002;38:977-85.
13. Paramo JC, Summerall J, Poppiti R, Mesko TW. Validation of sentinel node mappin in patients with colon cancer. Ann Surg Oncol 2002;9: 550-4.
14. Bendavid Y, Latulippe JF, Younan RJ, Leclerc YE, Dube S, Heyen F, et al. Phase I study on sentinel lymph node mapping in colon cancer: a preliminary report. J Surg Oncol 2002;79:81-4.
15. Saha S, Nora D, Wong JH, Weise D. Sentinel lymph node mapping in colorectal cancer. A review. Surg Clin North Am 2000;80:1811-9.
16. Tsioulias GJ, Wood TF, Morton DL, Bilchik AJ. Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastro-intestinal neoplasms. Arch Surg 2000;135:926-32.
17. Bilchick AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 2001;19:1128-36.
18. Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutcchinson W, et al. Validation of lymphatic mapping in colorectal cancer: In vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 2001;8: 150-7.
19. Salmon RJ, Nos C, Lojodice F, Languille O, Remvikos Y, Vilcoq JR, et al. Ganglion sentinelle et cancer opérable du sein: utilisation du bleu patent. Étude pilote. Ann Chir 2000;125:253-8.
20. Paraf F, Sabourin J-C. Nombre optimal de ganglions lymphatiques et métastases ganglionnaires occultes dans les cancers colorectaux: point de vue du pathologiste. Gastroenterol Clin Biol 2000;24:423-9.
21. Greeson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994;73:563-9.
22. Öberg A, Stenling R, Tavelin B, Lindmark G. Are lymph node micrometastasis of any clinical significance in Dukes stages A and B colorectal cancer? Dis Colon Rectum 1998;41:1244-9.